Xylem Inc. $XYL Stock Holdings Cut by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company reduced its position in shares of Xylem Inc. (NYSE:XYL) by 6.9% during the first quarter, Holdings Channel.com reports. The fund owned 129,275 shares of the industrial products company’s stock after selling 9,553 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Xylem were worth $15,444,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Commonwealth Retirement Investments LLC acquired a new position in shares of Xylem in the 4th quarter worth approximately $27,000. Wexford Capital LP acquired a new stake in Xylem during the third quarter valued at approximately $27,000. Global Assets Advisory LLC acquired a new stake in Xylem during the first quarter valued at approximately $40,000. FWL Investment Management LLC bought a new stake in Xylem during the second quarter worth approximately $43,000. Finally, Entrust Financial LLC bought a new stake in Xylem during the fourth quarter worth approximately $45,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Stock Up 0.3%

XYL opened at $117.29 on Monday. The business has a 50 day moving average price of $115.23 and a 200 day moving average price of $122.01. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61. Xylem Inc. has a twelve month low of $105.29 and a twelve month high of $154.27. The firm has a market cap of $27.39 billion, a P/E ratio of 27.93, a price-to-earnings-growth ratio of 1.62 and a beta of 1.02.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.12. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The business had revenue of $2.34 billion during the quarter, compared to analysts’ expectations of $2.34 billion. During the same quarter in the previous year, the firm earned $1.26 EPS. The firm’s revenue was up 1.5% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Research analysts forecast that Xylem Inc. will post 5.67 EPS for the current year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were paid a $0.43 dividend. The ex-dividend date was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. Xylem’s dividend payout ratio is currently 40.95%.

Insider Activity at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. UBS Group boosted their target price on Xylem from $129.00 to $135.00 and gave the stock a “neutral” rating in a research report on Thursday. Stifel Nicolaus lifted their price target on Xylem from $157.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday. CLSA upgraded Xylem to a “hold” rating in a report on Thursday, June 25th. JPMorgan Chase & Co. reduced their price objective on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Finally, Oppenheimer decreased their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a report on Wednesday, April 29th. Nine investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $154.00.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.